Gastric dysplasia in random biopsies: the influence of Helicobacter pylori infection and alcohol consumption in the presence of a lesion

References

• Smyth EC, Nilsson M, Grabsch HI, et al. Gastric cancer. Lancet. 2020;396(10251):635–648. doi: 10.1016/S0140-6736(20)31288-5.
   PubMed Web of Science ®Google Scholar
• Pimentel-Nunes P, Libânio D, Marcos-Pinto R, et al. Management of epithelial precancerous conditions and lesions in the stomach (MAPS II): European society of gastrointestinal endoscopy (ESGE), european helicobacter and microbiota study group (EHMSG), European Society of Pathology (ESP), and sociedade Portuguesa de endoscopia digestiva (SPED) guideline update 2019. Endoscopy. 2019;51(4):365–388. doi: 10.1055/a-0859-1883.
   PubMed Web of Science ®Google Scholar
• Hunt RH, Camilleri M, Crowe SE, et al. The stomach in health and disease. Gut. 2015;64(10):1650–1668. doi: 10.1136/gutjnl-2014-307595.
   PubMed Web of Science ®Google Scholar
• Waddingham W, Nieuwenburg SAV, Carlson S, et al. Recent advances in the detection and management of early gastric cancer and its precursors. Frontline Gastroenterol. 2021;12(4):322–331. doi: 10.1136/flgastro-2018-101089.
   PubMed Web of Science ®Google Scholar
• White JR, Banks M. Identifying the pre-malignant stomach: from guidelines to practice. Transl Gastroenterol Hepatol. 2022;7:8–8. doi: 10.21037/tgh.2020.03.03.
   PubMedGoogle Scholar
• Sung JK. Diagnosis and management of gastric dysplasia. Korean J Intern Med. 2016;31(2):201–209. doi: 10.3904/kjim.2016.021.
   PubMed Web of Science ®Google Scholar
• Akbari M, Kardeh B, Tabrizi R, et al. Incidence rate of gastric cancer adenocarcinoma in patients With gastric dysplasia: a systematic review and meta-analysis. J Clin Gastroenterol. 2019;53(10):703–710. doi: 10.1097/MCG.0000000000001257.
   PubMed Web of Science ®Google Scholar
• Kwon MJ, Kang HS, Kim HT, et al. Treatment for gastric ‘indefinite for neoplasm/dysplasia’ lesions based on predictive factors. World J Gastroenterol. 2019;25(4):469–484. doi: 10.3748/wjg.v25.i4.469.
   PubMed Web of Science ®Google Scholar
• Rokkas T, Rokka A, Portincasa P. A systematic review and meta-analysis of the role of Helicobacter pylori eradication in preventing gastric cancer. Ann Gastroenterol. 2017;30(4):414–423.
   PubMed Web of Science ®Google Scholar
• Shichijo S, Hirata Y, Niikura R, et al. Histologic intestinal metaplasia and endoscopic atrophy are predictors of gastric cancer development after Helicobacter pylori eradication. Gastrointest Endosc. 2016;84(4):618–624. doi: 10.1016/j.gie.2016.03.791.
   PubMed Web of Science ®Google Scholar
• Bisschops R, Areia M, Coron E, et al. Performance measures for upper gastrointestinal endoscopy: a european society of gastrointestinal endoscopy quality improvement initiative. United Eur Gastroenterol J. 2016;4(5):629–656. doi: 10.1177/2050640616664843.
   PubMed Web of Science ®Google Scholar
• Banks M, Graham D, Jansen M, et al. British society of gastroenterology guidelines on the diagnosis and management of patients at risk of gastric adenocarcinoma. Gut. 2019;68(9):1545–1575. doi: 10.1136/gutjnl-2018-318126.
   PubMed Web of Science ®Google Scholar
• Pouw RE, Barret M, Biermann K, et al. Endoscopic tissue sampling - Part 1: upper gastrointestinal and hepatopancreatobiliary tracts. European society of gastrointestinal endoscopy (ESGE) guideline. Endoscopy. 2021;53(11):1174–1188. doi: 10.1055/a-1611-5091.
   PubMed Web of Science ®Google Scholar
• de Vries AC, van Grieken NC, Looman CW, et al. Gastric cancer risk in patients with premalignant gastric lesions: a nationwide cohort study in The Netherlands. Gastroenterology. 2008;134(4):945–952. doi: 10.1053/j.gastro.2008.01.071.
   PubMed Web of Science ®Google Scholar
• Sugano K, Tack J, Kuipers EJ, et al. Kyoto global consensus report on Helicobacter pylori gastritis. Gut. 2015;64(9):1353–1367. doi: 10.1136/gutjnl-2015-309252.
   PubMed Web of Science ®Google Scholar
• Pimentel-Nunes P, Libânio D, Lage J, et al. A multicenter prospective study of the real-time use of narrow-band imaging in the diagnosis of premalignant gastric conditions and lesions. Endoscopy. 2016;48(8):723–730. doi: 10.1055/s-0042-108435.
   PubMed Web of Science ®Google Scholar
• Song J, Zhang J, Wang J, et al. Meta-analysis: narrow band imaging for diagnosis of gastric intestinal metaplasia. PLoS One. 2014;9(4):e94869. doi: 10.1371/journal.pone.0094869.
   PubMed Web of Science ®Google Scholar
• Ang TL, Pittayanon R, Lau JY, et al. A multicenter randomized comparison between high-definition white light endoscopy and narrow band imaging for detection of gastric lesions. Eur J Gastroenterol Hepatol. 2015;27(12):1473–1478. doi: 10.1097/MEG.0000000000000478.
   PubMed Web of Science ®Google Scholar
• Zhang Q, Wang F, Chen ZY, et al. Comparison of the diagnostic efficacy of white light endoscopy and magnifying endoscopy with narrow band imaging for early gastric cancer: a meta-analysis. Gastric Cancer. 2016;19(2):543–552. doi: 10.1007/s10120-015-0500-5.
   PubMed Web of Science ®Google Scholar
• Kikuste I, Marques-Pereira R, Monteiro-Soares M, et al. Systematic review of the diagnosis of gastric premalignant conditions and neoplasia with high-resolution endoscopic technologies. Scand J Gastroenterol. 2013;48(10):1108–1117. doi: 10.3109/00365521.2013.825315.
   PubMed Web of Science ®Google Scholar
• Simone A, Casadei A, De Vergori E, et al. Rescue endoscopy to identify site of gastric dysplasia or carcinoma found at random biopsies. Dig Liver Dis. 2011;43(9):721–725. Sepdoi: 10.1016/j.dld.2011.04.007.
   PubMedGoogle Scholar
• Dinis-Ribeiro M, da Costa-Pereira A, Lopes C, et al. Magnification chromoendoscopy for the diagnosis of gastric intestinal metaplasia and dysplasia. Gastrointest Endosc. 2003;57(4):498–504. doi: 10.1067/mge.2003.145.
   PubMed Web of Science ®Google Scholar
• Gong EJ, Lee JH, Jung K, et al. Characteristics of missed simultaneous gastric lesions based on double-check analysis of the endoscopic image. Clin Endosc. 2017;50(3):261–269. doi: 10.5946/ce.2016.056.
   PubMedGoogle Scholar
• Pimenta-Melo AR, Monteiro-Soares M, Libânio D, et al. Missing rate for gastric cancer during upper gastrointestinal endoscopy: a systematic review and meta-analysis. Eur J Gastroenterol Hepatol. 2016;28(9):1041–1049. doi: 10.1097/MEG.0000000000000657.
   PubMed Web of Science ®Google Scholar
• Aumpan N, Vilaichone RK, Pornthisarn B, et al. Predictors for regression and progression of intestinal metaplasia (IM): a large population-based study from low prevalence area of gastric cancer (IM-predictor trial). PLoS One. 2021;16(8):e0255601. doi: 10.1371/journal.pone.0255601.
   PubMed Web of Science ®Google Scholar
• Abadir A, Streutker C, Brezden-Masley C, et al. Intestinal metaplasia and the risk of gastric cancer in an immigrant asian population. Clin Med Insights Gastroenterol. 2012;5:43–50. doi: 10.4137/CGast.S10070.
   PubMedGoogle Scholar
• Li D, Bautista MC, Jiang SF, et al. Risks and predictors of gastric adenocarcinoma in patients with gastric intestinal metaplasia and dysplasia: a population-based study. Am J Gastroenterol. 2016;111(8):1104–1113. doi: 10.1038/ajg.2016.188.
   PubMed Web of Science ®Google Scholar
• den Hollander WJ, Holster IL, den Hoed CM, et al. Surveillance of premalignant gastric lesions: a multicentre prospective cohort study from low incidence regions. Gut. 2019;68(4):585–593. doi: 10.1136/gutjnl-2017-314498.
   PubMed Web of Science ®Google Scholar
• Malfertheiner P, Megraud F, Rokkas T, et al. Management of Helicobacter pylori infection: the maastricht VI/florence consensus report. Gut. 2022;71(9):1724–1762. doi: 10.1136/gutjnl-2022-327745.
   Web of Science ®Google Scholar
• Malfertheiner P, Megraud F, O’Morain CA, et al. Management of Helicobacter pylori infection-the maastricht V/florence consensus report. Gut. 2017;66(1):6–30. doi: 10.1136/gutjnl-2016-312288.
   PubMed Web of Science ®Google Scholar
• Smyth EC, Verheij M, Allum W, et al. Gastric cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2016;27(suppl 5):v38–v49. doi: 10.1093/annonc/mdw350.
   PubMed Web of Science ®Google Scholar
• Jung DH, Kim JH, Chung HS, et al. Helicobacter pylori eradication on the prevention of metachronous lesions after endoscopic resection of gastric neoplasm: a meta-analysis. PLoS One. 2015;10(4):e0124725. doi: 10.1371/journal.pone.0124725.
   PubMed Web of Science ®Google Scholar
• Choi IJ, Kook MC, Kim YI, et al. Helicobacter pylori therapy for the prevention of metachronous gastric cancer. N Engl J Med. 2018;378(12):1085–1095. doi: 10.1056/NEJMoa1708423.
   PubMed Web of Science ®Google Scholar
• Zhao B, Zhang J, Mei D, et al. Does Helicobacter pylori eradication reduce the incidence of metachronous gastric cancer after curative endoscopic resection of early gastric cancer: a systematic review and meta-analysis. J Clin Gastroenterol. 2020;54(3):235–241. doi: 10.1097/MCG.0000000000001195.
   PubMed Web of Science ®Google Scholar
• Rokkas T, Pistiolas D, Sechopoulos P, et al. The long-term impact of Helicobacter pylori eradication on gastric histology: a systematic review and meta-analysis. Helicobacter. 2007;12 Suppl 2:32–38. doi: 10.1111/j.1523-5378.2007.00563.x.
   PubMedGoogle Scholar
• Liu KS, Wong IO, Leung WK. Helicobacter pylori associated gastric intestinal metaplasia: treatment and surveillance. World J Gastroenterol. 2016;22(3):1311–1320. doi: 10.3748/wjg.v22.i3.1311.
   PubMed Web of Science ®Google Scholar
• Kodama M, Murakami K, Okimoto T, et al. Ten-year prospective follow-up of histological changes at five points on the gastric mucosa as recommended by the updated sydney system after Helicobacter pylori eradication. J Gastroenterol. 2012;47(4):394–403. doi: 10.1007/s00535-011-0504-9.
   PubMed Web of Science ®Google Scholar
• Hwang YJ, Kim N, Lee HS, et al. Reversibility of atrophic gastritis and intestinal metaplasia after Helicobacter pylori eradication - a prospective study for up to 10 years. Aliment Pharmacol Ther. 2018;47(3):380–390. doi: 10.1111/apt.14424.
   PubMed Web of Science ®Google Scholar
• Chiang TH, Chang WJ, Chen SL, et al. Mass eradication of Helicobacter pylori to reduce gastric cancer incidence and mortality: a long-term cohort study on matsu islands. Gut. 2021;70(2):243–250.
   PubMed Web of Science ®Google Scholar
• Leung WK, Lin SR, Ching JY, et al. Factors predicting progression of gastric intestinal metaplasia: results of a randomised trial on Helicobacter pylori eradication. Gut. 2004;53(9):1244–1249. doi: 10.1136/gut.2003.034629.
   PubMed Web of Science ®Google Scholar
• Duell EJ, Travier N, Lujan-Barroso L, et al. Alcohol consumption and gastric cancer risk in the european prospective investigation into cancer and nutrition (EPIC) cohort. Am J Clin Nutr. 2011;94(5):1266–1275. doi: 10.3945/ajcn.111.012351.
   PubMed Web of Science ®Google Scholar
• Tramacere I, Negri E, Pelucchi C, et al. A meta-analysis on alcohol drinking and gastric cancer risk. Ann Oncol. 2012;23(1):28–36. doi: 10.1093/annonc/mdr135.
   PubMed Web of Science ®Google Scholar
• Buckland G, Travier N, Huerta JM, et al. Healthy lifestyle index and risk of gastric adenocarcinoma in the EPIC cohort study. Int J Cancer. 2015;137(3):598–606. doi: 10.1002/ijc.29411.
   PubMed Web of Science ®Google Scholar
• den Hoed CM, Kuipers EJ. Gastric cancer: how can we reduce the incidence of this disease? Curr Gastroenterol Rep. 2016;18(7):34. doi: 10.1007/s11894-016-0506-0.
   PubMedGoogle Scholar
• Dong Y, Chen J, Chen Z, et al. Evaluating the association of eight polymorphisms with cancer susceptibility in a Han Chinese population. PLoS One. 2015;10(7):e0132797. doi: 10.1371/journal.pone.0132797.
   PubMed Web of Science ®Google Scholar
• Benjamin JB, Jayanthi V, Devaraj H. MUC1 expression and its association with other aetiological factors and localization to mitochondria in preneoplastic and neoplastic gastric tissues. Clin Chim Acta. 2010;411(23–24):2067–2072. doi: 10.1016/j.cca.2010.09.003.
   PubMed Web of Science ®Google Scholar
• Yaghoobi M, Bijarchi R, Narod SA. Family history and the risk of gastric cancer. Br J Cancer. 2010;102(2):237–242. doi: 10.1038/sj.bjc.6605380.
   PubMed Web of Science ®Google Scholar
• Nishizawa T, Suzuki H, Sakitani K, et al. Family history is an independent risk factor for the progression of gastric atrophy among patients with Helicobacter pylori infection. United Eur Gastroenterol J. 2017;5(1):32–36. doi: 10.1177/2050640616642341.
   PubMed Web of Science ®Google Scholar
• Nieuwenburg SAV, Mommersteeg MC, Eikenboom EL, et al. Factors associated with the progression of gastric intestinal metaplasia: a multicenter, prospective cohort study. Endosc Int Open. 2021;9(3):E297–E305. doi: 10.1055/a-1314-6626.
   PubMedGoogle Scholar
• Rokkas T, Sechopoulos P, Pistiolas D, et al. Helicobacter pylori infection and gastric histology in first-degree relatives of gastric cancer patients: a meta-analysis. Eur J Gastroenterol Hepatol. 2010;22(9):1128–1133. doi: 10.1097/MEG.0b013e3283398d37.
   PubMed Web of Science ®Google Scholar
• Poorolajal J, Moradi L, Mohammadi Y, et al. Risk factors for stomach cancer: a systematic review and meta-analysis. Epidemiol Health. 2020;42:e2020004. doi: 10.4178/epih.e2020004.
   PubMed Web of Science ®Google Scholar
• Park SK, Kim MH, Oh CM, et al. The risk of gastric cancer according to changes in smoking status among korean men. Epidemiol Health. 2022;44:e2022086. doi: 10.4178/epih.e2022086.
   PubMed Web of Science ®Google Scholar
• Praud D, Rota M, Pelucchi C, et al. Cigarette smoking and gastric cancer in the stomach cancer pooling (StoP) project. Eur J Cancer Prev. 2018;27(2):124–133. doi: 10.1097/CEJ.0000000000000290.
   PubMed Web of Science ®Google Scholar